Liraglutide dictates macrophage phenotype in apolipoprotein E null mice during early atherosclerosis

被引：0
|
作者：
Robyn Bruen
Sean Curley
Sarina Kajani
Daniel Crean
Marcella E. O’Reilly
Margaret B. Lucitt
Catherine G. Godson
Fiona C. McGillicuddy
Orina Belton
机构：
[1] UCD Conway Institute,Diabetes Complications Research Centre, School of Biomolecular and Biomedical Science
[2] University College Dublin,Diabetes Complications Research Centre, School of Medicine
[3] UCD Conway Institute,Diabetes Complications Research Centre, School of Veterinary Medicine
[4] University College Dublin,School of Medicine, Department of Pharmacology and Therapeutics
[5] UCD Conway Institute,undefined
[6] University College Dublin,undefined
[7] Trinity College Dublin,undefined
[8] The University of Dublin,undefined
来源：
Cardiovascular Diabetology | / 16卷
关键词：
MΦ2 macrophages; Monocytes; Anti-inflammatory; Plaque microenvironment; Atherosclerosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Anti-atherogenic effects of liraglutide independent of the AMPK pathway in diabetic apolipoprotein E-null mice
    Koshibu, M.
    Mori, Y.
    Kushima, H.
    Kohashi, K.
    Hiromura, M.
    Terasaki, M.
    Fukui, T.
    Hirano, T.
    DIABETOLOGIA, 2017, 60 : S528 - S528
  • [32] Deficiency of Glycine N-Methyltransferase Aggravates Atherosclerosis in Apolipoprotein E-Null Mice
    Chen, Chien-Yu
    Ching, Li-Chieh
    Liao, Yi-Jen
    Yu, Yuan-Bin
    Tsou, Chia-Yuan
    Shyue, Song-Kun
    Chen, Yi-Ming Arthur
    Lee, Tzong-Shyuan
    MOLECULAR MEDICINE, 2012, 18 (05) : 744 - 752
  • [33] Reduction of plasma glycosphingolipid levels has no impact on atherosclerosis in apolipoprotein E-null mice
    Glaros, Elias N.
    Kim, Woojin S.
    Rye, Kerry-Anne
    Shayman, James A.
    Garner, Brett
    JOURNAL OF LIPID RESEARCH, 2008, 49 (08) : 1677 - 1681
  • [34] Loss of Insulin Signaling in Vascular Endothelial Cells Accelerates Atherosclerosis in Apolipoprotein E Null Mice
    Rask-Madsen, Christian
    Li, Qian
    Freund, Bryn
    Feather, Danielle
    Abramov, Roman
    Wu, I-Hsien
    Chen, Kai
    Yamamoto-Hiraoka, Junko
    Goldenbogen, Jan
    Sotiropoulos, Konstantinos B.
    Clermont, Allen
    Geraldes, Pedro
    Dall'Osso, Claudia
    Wagers, Amy J.
    Huang, Paul L.
    Rekhter, Mark
    Scalia, Rosario
    Kahn, C. Ronald
    King, George L.
    CELL METABOLISM, 2010, 11 (05) : 379 - 389
  • [35] Differential effects of apolipoprotein A-I-mimetic peptide on evolving and established atherosclerosis in apolipoprotein E-null mice
    Li, XJ
    Chyu, KY
    Neto, JRF
    Yano, J
    Nathwani, N
    Ferreira, C
    Dimayuga, PC
    Cercek, B
    Kaul, S
    Shah, PK
    CIRCULATION, 2004, 110 (12) : 1701 - 1705
  • [36] ASSOCIATION IN EARLY ATHEROSCLEROSIS WITH RENAL FIBROSIS IN APOLIPOPROTEIN E-DEFICIENT MICE
    Tonini, G.
    de Paiva, V. Nunes
    Camara, N.
    Gidlund, M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [37] Central roles for PKCβ early growth response-1 (Egr-1) axis in atherosclerosis in apolipoprotein E null mice
    Harja, E
    Lu, Y
    Zou, YS
    Hudson, BI
    Schmidt, AM
    Yan, SF
    CIRCULATION, 2003, 108 (17) : 301 - 301
  • [38] Macrophage apolipoprotein E reduces atherosclerosis and prevents premature death in apolipoprotein E and scavenger receptor class BI double knockout mice
    Yu, H
    Yancey, PG
    Zhang, WW
    Zhang, YM
    Fazio, S
    Linton, MF
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (05) : E95 - E95
  • [39] Elimination of macrophage-specific apolipoprotein E reduces diet-induced atherosclerosis in mice
    Boisvert, WA
    Curtiss, LK
    CIRCULATION, 1996, 94 (08) : 3036 - 3036
  • [40] Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice
    Shi, WB
    Wang, XP
    Wong, J
    Hedrick, CC
    Wong, H
    Castellani, LW
    Lusis, AJ
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 317 (01) : 223 - 229
12345